Ujjal Didar Singh Sekhon

Ujjal Didar Singh Sekhon's work experience can be summarized as follows:

- Senior Scientist at Haima Therapeutics (2023 - present): Ujjal is responsible for developing cell-inspired therapies for the treatment of bleeding and various blood-related diseases. Ujjal Didar Singh focuses on platelet-inspired therapies using Haima's lead technology, SynthoPlate, a fully-synthetic hemostatic agent that supports natural clotting mechanisms.

- Scientist II at Haima Therapeutics (2022 - 2023): Ujjal worked as a scientist, contributing to the development of cell-inspired therapies for bleeding and blood-related diseases.

- Scientist I at Haima Therapeutics (2021 - 2022): Ujjal started their journey with Haima Therapeutics as a scientist, where they were involved in the initial stages of developing cell-inspired therapies.

- Scientific Program Manager at ADLD Center (2022 - present): Ujjal holds the position of scientific program manager at ADLD Center, where they manage and oversees scientific programs.

- Graduate Research Assistant, Graduate Teaching Assistant, and Research Assistant at Case School of Engineering at Case Western Reserve University (2014 - 2021): Ujjal served multiple roles during their time at Case Western Reserve University. Ujjal Didar Singh was a graduate research assistant, graduate teaching assistant, and research assistant, contributing to various research projects in the field of engineering.

- Intern at Panacea Biotec Ltd (2013): Ujjal gained experience as an intern at Panacea Biotec Ltd, where they worked on assigned projects.

- Intern at Indian Institute of Technology, Roorkee (2012): Ujjal worked as an intern at the Indian Institute of Technology, Roorkee, gaining practical knowledge in a research environment.

Ujjal Didar Singh Sekhon pursued their education in a chronological manner, starting with a Bachelor of Engineering (BE) degree in Biotechnology Engineering from Panjab University. Ujjal Didar Singh attended this institution from 2010 to 2014. Following this, they furthered their studies by enrolling in Case Western Reserve University, where they obtained a Doctor of Philosophy (Ph.D.) degree in Biomedical/Medical Engineering. Ujjal Didar Singh completed their Ph.D. program from 2015 to 2020. In addition to their academic degrees, Ujjal obtained a certification in Recorded Drug Development Immersion from Biotech Primer in June 2023.